YZi Labs
Jul 3, 2026

YZi Labs’ $10 Billion Investment Map Across Crypto, AI, and Biotech

YZi Labs, Binance’s investment and incubation arm, manages more than $10 billion in assets and has backed over 300 projects across 25 countries. Its structure stands out because it combines the characteristics of a family office, a venture capital firm, and an industry platform, allowing it to deploy long-term capital while also supporting portfolio companies with strategic resources. The firm’s key focus areas include crypto, artificial intelligence, and biotechnology. Unlike many traditional funds, YZi Labs emphasizes a long-term holding approach and does not operate around a fixed exit window. The platform may also open to external investors in the future, signaling potential expansion beyond its current internal capital base. On the incubation side, YZi Labs is also building founder infrastructure through initiatives such as EASY Residency, which provides funding, resources, and community support for entrepreneurs.

860
YZi Labs’ $10 Billion Investment Map Across Crypto, AI, and Biotech
YZi Labs
Jul 3, 2026

YZi Labs Oversees More Than $10 Billion as CZ-Linked Investment Platform Expands Across Crypto, AI and Biotech

YZi Labs, Binance’s investment and incubation arm, manages more than $10 billion in assets and has backed over 300 projects across 25 countries. The platform combines characteristics of a family office, a venture capital firm, and an industry platform, giving it a broader operating model than a traditional crypto fund. Its current focus spans crypto, artificial intelligence, and biotechnology, showing a cross-sector investment strategy beyond digital assets alone. YZi Labs also emphasizes a long-term holding approach without a predefined exit window, differentiating it from funds built around standard liquidity timelines. In addition, the firm may eventually open up to external investors. On the incubation side, its EASY Residency program provides capital and operational resources designed to support founders and help build a dedicated founder community.

690
YZi Labs Oversees More Than $10 Billion as CZ-Linked Investment Platform Expands Across Crypto, AI and Biotech
YZi Labs
Jul 3, 2026

YZi Labs’ $10 Billion Investment Footprint Across Crypto, AI, and Biotech

YZi Labs, Binance’s investment and incubation arm, manages more than $10 billion in assets and has backed over 300 projects across 25 countries. Its structure goes beyond a standard venture capital firm, combining elements of a family office, VC fund, and industry platform. The firm is allocating capital across three core verticals: crypto, artificial intelligence, and biotechnology. Unlike traditional funds that operate on fixed exit cycles, YZi Labs emphasizes a long-term holding strategy without a predefined exit window, signaling a more flexible and conviction-driven investment approach. The platform is also building founder infrastructure through EASY Residency, an incubation initiative that provides capital and operational resources while aiming to form a stronger founder community. In addition, YZi Labs has indicated that it may eventually open to external investors, a move that could broaden its role from internal strategic capital vehicle to a larger investment platform.

710
YZi Labs’ $10 Billion Investment Footprint Across Crypto, AI, and Biotech
Binance
Jun 30, 2026

CZ Deep Dive: Crypto Cycle Bottom Rises, 70% Allocation to Crypto, 20% AI, 10% Biotech; Invests in Artificial Womb and Knee Cartilage Regeneration

In a comprehensive interview with Galaxy, Binance founder CZ shares his views on market cycles, the convergence of crypto and traditional finance, decentralization, Layer 2 vs Layer 1, Hyperliquid's innovation, prediction markets like Polymarket, and his personal investment philosophy. He believes the current cycle bottom is significantly higher than previous lows (BTC support around $60k), and industry leverage is better controlled. Crypto and TradFi will inevitably merge, with centralization and decentralization coexisting. CZ reveals Yzi Labs' investment heuristic: 70% crypto, 20% AI, 10% biotech, including investments in an artificial womb company (tested on mice, human application 5-10 years away) and knee cartilage regeneration technology (3D-printed scaffold). He also compares Chinese and US AI models, emphasizing that AI regulation is far more complex than crypto, and that the future financial system will be built collaboratively by AI, blockchain, and the internet.

1120
CZ Deep Dive: Crypto Cycle Bottom Rises, 70% Allocation to Crypto, 20% AI, 10% Biotech; Invests in Artificial Womb and Knee Cartilage Regeneration
CZ
Jun 30, 2026

CZ Deep Dive: 70% Crypto, 20% AI, 10% Biotech — Market Cycles, Centralization vs Decentralization, Prediction Markets, and Vision for the Future

In an extensive interview with Galaxy, CZ shared his macro outlook on the crypto market: the current drawdown of ~50% is normal, but each cycle's floor is higher, with historical highs (e.g., $60,000) likely acting as future support. He sees inevitable convergence between crypto and traditional finance into one fintech sector, and that centralization and decentralization will coexist indefinitely, with technology pushing toward the latter. CZ praised Hyperliquid for carving out a niche Binance cannot compete in, and backed prediction markets like Polymarket and Kalshi. He disclosed Yzi Labs' portfolio allocation: 70% crypto, 20% AI, 10% biotech, notable bets include an "artificial womb" (tested on mice, 5-10 years from human use) and a knee cartilage regeneration technology using 3D-printed scaffolds. He stressed that investment aims for impact over ROI, and warned that AI poses existential risks far greater than crypto, urging careful regulation.

990
CZ Deep Dive: 70% Crypto, 20% AI, 10% Biotech — Market Cycles, Centralization vs Decentralization, Prediction Markets, and Vision for the Future
CZ
Jun 30, 2026

CZ on the Future: Crypto Cycles, 70/20/10 Portfolio, and Investments in Artificial Wombs and Knee Regeneration

In a comprehensive interview with Galaxy, Binance founder CZ shared his views on the current crypto market cycle, emphasizing higher bottoms each cycle and improved leverage control. He revealed Yzi Labs' investment framework: 70% crypto, 20% AI, 10% biotech, with specific investments in artificial womb technology (tested on mice) and 3D-printed knee cartilage regeneration. CZ discussed the inevitable convergence of traditional finance and crypto, the innovation of perpetual contracts, prediction markets, and Hyperliquid. He also contrasted AI risks (potential to destroy civilization) with crypto safety, urging careful AI regulation while noting that crypto flows will ultimately benefit from AI activity on-chain.

830
CZ on the Future: Crypto Cycles, 70/20/10 Portfolio, and Investments in Artificial Wombs and Knee Regeneration
CZ
Jun 30, 2026

CZ on Crypto Cycles, Portfolio Strategy, and the AI Future: 70% Crypto, 20% AI, 10% Biotech

In a detailed interview with Galaxy, Binance founder Changpeng Zhao (CZ) shared his macro outlook on the crypto market, emphasizing that the four-year cycle continues with rising bottoms and healthier leverage among institutions. He revealed Yzi Labs' investment allocation: 70% crypto, 20% AI, 10% biotech, with bets on startups developing artificial wombs and knee cartilage regeneration. CZ also discussed the convergence of crypto and traditional finance, the role of perpetuals and prediction markets, the L1 vs L2 debate, and his belief that while AI could pose existential risks, it will ultimately rely on blockchain infrastructure.

870
CZ on Crypto Cycles, Portfolio Strategy, and the AI Future: 70% Crypto, 20% AI, 10% Biotech
Total 41 items
Go topage